<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>TNM staging for colorectal cancer, 7th edition</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">TNM staging for colorectal cancer, 7th edition</h1>
<div class="graphic"><div class="figure"><div class="ttl">TNM staging for colorectal cancer, 7th edition</div><div class="cntnt"><table cellspacing="0"><colgroup width="10%"></colgroup><colgroup span="5" width="18%"></colgroup> <tbody> <tr> <td class="subtitle1_single" colspan="6">Primary tumor (T)</td> </tr> <tr> <td>TX</td> <td colspan="5">Primary tumor cannot be assessed</td> </tr> <tr> <td>T0</td> <td colspan="5">No evidence of primary tumor</td> </tr> <tr> <td>Tis</td> <td colspan="5">Carcinoma in situ: intraepithelial or invasion of lamina propria*</td> </tr> <tr> <td>T1</td> <td colspan="5">Tumor invades submucosa</td> </tr> <tr> <td>T2</td> <td colspan="5">Tumor invades muscularis propria</td> </tr> <tr> <td>T3</td> <td colspan="5">Tumor invades through the muscularis propria into pericolorectal tissues</td> </tr> <tr> <td>T4a</td> <td colspan="5">Tumor penetrates to the surface of the visceral peritoneum<sup>¶</sup></td> </tr> <tr> <td>T4b</td> <td colspan="5">Tumor directly invades or is adherent to other organs or structures<sup>¶</sup><sup>Δ</sup></td> </tr> <tr> <td class="subtitle1_single" colspan="6">Regional lymph node (N)<sup>◊</sup></td> </tr> <tr> <td>NX</td> <td colspan="5">Regional lymph nodes cannot be assessed</td> </tr> <tr> <td>N0</td> <td colspan="5">No regional lymph node metastasis</td> </tr> <tr> <td class="sublist1_start">N1</td> <td class="sublist_other_start" colspan="5">Metastasis in one to three regional lymph nodes</td> </tr> <tr> <td class="sublist1">N1a</td> <td class="sublist_other" colspan="5">Metastasis in one regional lymph node</td> </tr> <tr> <td class="sublist1">N1b</td> <td class="sublist_other" colspan="5">Metastasis in two to three regional lymph nodes</td> </tr> <tr> <td class="sublist1">N1c</td> <td class="sublist_other" colspan="5">Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis</td> </tr> <tr> <td>N2</td> <td colspan="5">Metastasis in four or more regional lymph nodes</td> </tr> <tr> <td class="sublist1">N2a</td> <td class="sublist_other" colspan="5">Metastasis in four to six regional lymph nodes</td> </tr> <tr> <td class="sublist1">N2b</td> <td class="sublist_other" colspan="5">Metastasis in seven or more regional lymph nodes</td> </tr> <tr> <td class="subtitle1_single" colspan="6">Distant metastasis (M)</td> </tr> <tr> <td>M0</td> <td colspan="5">No distant metastasis</td> </tr> <tr> <td class="sublist1_start">M1</td> <td class="sublist_other_start" colspan="5">Distant metastasis</td> </tr> <tr> <td class="sublist1">M1a</td> <td class="sublist_other" colspan="5">Metastasis confined to one organ or site (eg, liver, lung, ovary, nonregional node)</td> </tr> <tr> <td class="sublist1">M1b</td> <td class="sublist_other" colspan="5">Metastases in more than one organ/site or the peritoneum</td> </tr> <tr> <td class="subtitle1_single" colspan="6">Anatomic stage/prognostic groups<sup>§</sup></td> </tr> <tr> <td class="subtitle2">Stage</td> <td class="subtitle2">T</td> <td class="subtitle2">N</td> <td class="subtitle2">M</td> <td class="subtitle2">Dukes<sup>¥</sup></td> <td class="subtitle2">MAC<sup>¥</sup></td> </tr> <tr> <td>0</td> <td>Tis</td> <td>N0</td> <td>M0</td> <td>–</td> <td>–</td> </tr> <tr> <td rowspan="2">I</td> <td>T1</td> <td>N0</td> <td>M0</td> <td>A</td> <td>A</td> </tr> <tr> <td>T2</td> <td>N0</td> <td>M0</td> <td>A</td> <td>B1</td> </tr> <tr> <td>IIA</td> <td>T3</td> <td>N0</td> <td>M0</td> <td>B</td> <td>B2</td> </tr> <tr> <td>IIB</td> <td>T4a</td> <td>N0</td> <td>M0</td> <td>B</td> <td>B2</td> </tr> <tr> <td>IIC</td> <td>T4b</td> <td>N0</td> <td>M0</td> <td>B</td> <td>B3</td> </tr> <tr> <td rowspan="2">IIIA</td> <td>T1 to T2</td> <td>N1/N1c</td> <td>M0</td> <td>C</td> <td>C1</td> </tr> <tr> <td>T1</td> <td>N2a</td> <td>M0</td> <td>C</td> <td>C1</td> </tr> <tr> <td rowspan="3">IIIB</td> <td>T3 to T4a</td> <td>N1/N1c</td> <td>M0</td> <td>C</td> <td>C2</td> </tr> <tr> <td>T2 to T3</td> <td>N2a</td> <td>M0</td> <td>C</td> <td>C1/C2</td> </tr> <tr> <td>T1 to T2</td> <td>N2b</td> <td>M0</td> <td>C</td> <td>C1</td> </tr> <tr> <td rowspan="3">IIIC</td> <td>T4a</td> <td>N2a</td> <td>M0</td> <td>C</td> <td>C2</td> </tr> <tr> <td>T3 to T4a</td> <td>N2b</td> <td>M0</td> <td>C</td> <td>C2</td> </tr> <tr> <td>T4b</td> <td>N1 to N2</td> <td>M0</td> <td>C</td> <td>C3</td> </tr> <tr> <td>IVA</td> <td>Any T</td> <td>Any N</td> <td>M1a</td> <td>–</td> <td>–</td> </tr> <tr> <td>IVB</td> <td>Any T</td> <td>Any N</td> <td>M1b</td> <td>–</td> <td>–</td> </tr> </tbody></table></div><div class="graphic_footnotes">* Tis includes cancer cells confined within the glandular basement membrane (intraepithelial) or mucosal lamina propria (intramucosal) with no extension through the muscularis mucosae into the submucosa.<br/>¶ Direct invasion in T4 includes invasion of other organs or other segments of the colorectum as a result of direct extension through the serosa, as confirmed on microscopic examination (for example, invasion of the sigmoid colon by a carcinoma of the cecum) or, for cancers in a retroperitoneal or subperitoneal location, direct invasion of other organs or structures by virtue of extension beyond the muscularis propria (ie, respectively, a tumor on the posterior wall of the descending colon invading the left kidney or lateral abdominal wall; or a mid- or distal rectal cancer with invasion of prostate, seminal vesicles, cervix, or vagina).<br/>Δ Tumor that is adherent to other organs or structures, grossly, is classified cT4b. However, if no tumor is present in the adhesion microscopically, the classification should be pT1-4a depending on the anatomical depth of wall invasion. The V and L classifications should be used to identify the presence or absence of vascular or lymphatic invasion whereas the PN site-specific factor should be used for perineural invasion.<br/><font class="lozenge">◊</font> A satellite peritumoral nodule in the pericolorectal adipose tissue of a primary carcinoma without histologic evidence of residual lymph node in the nodule may represent discontinuous spread, venous invasion with extravascular spread (V1/2), or a totally replaced lymph node (N1/2). Replaced nodes should be counted separately as positive nodes in the N category, whereas discontinuous spread or venous invasion should be classified and counted in the Site-Specific Factor category Tumor Deposits (TD).<br/>§ cTNM is the clinical classification, pTNM is the pathologic classification. The y prefix is used for those cancers that are classified after neoadjuvant pretreatment (eg, ypTNM). Patients who have a complete pathologic response are ypT0N0cM0 that may be similar to Stage Group 0 or I. The r prefix is to be used for those cancers that have recurred after a disease-free interval (rTNM).<br/>¥ Dukes B is a composite of better (T3 N0 M0) and worse (T4 N0 M0) prognostic groups, as is Dukes C (Any TN1 M0 and Any T N2 M0). MAC is the modified Astler-Coller classification.</div><div class="graphic_reference">Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.</div><div id="graphicVersion">Graphic 72913 Version 18.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
